Weight loss drugs may become harder to get. What does that mean for patients?
On Point | Podcast
Challenges and Changes in the Weight Loss Drug Market
This chapter delves into the obstacles faced in the availability of weight loss drugs, especially compounded semaglutide, and examines the changing strategies of telehealth companies amid regulatory shifts. It concludes with a sponsorship highlight for a podcast focused on executive pay and shareholder influence.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
